Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Fish and Richardson
Argus Health
Julphar
Chinese Patent Office
Medtronic
Deloitte
Colorcon
Novartis
Farmers Insurance

Generated: August 16, 2017

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% Drug Profile

« Back to Dashboard

Which patents cover Lidocaine Hydrochloride 0.4% In Dextrose 5%, and when can generic versions of Lidocaine Hydrochloride 0.4% In Dextrose 5% launch?

Lidocaine Hydrochloride 0.4% In Dextrose 5% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for Tradename: LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list33
Clinical Trials: see list3,223
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% at DailyMed

Pharmacology for Tradename: LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
lidocaine hydrochloride
INJECTABLE;INJECTION083158-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018388-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Dow
Colorcon
Chinese Patent Office
McKinsey
US Army
Citi
Cerilliant
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot